Trials / Completed
CompletedNCT02879227
Radiochemotherapy in Elderly Patients With Oesophagus Cancer
Phase II of Radiochemotherapy in Elderly Patients With Oesophagus Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
Phase II study of radiochemotherapy for elderly patients with oesophagus cancer.
Detailed description
Phase II study of radiochemotherapy for elderly patients with oesophagus cancer with Radiotherapy = 50 Gy, 2Gy/f ans chemotherapy with 2 arms arm Cisplatin = Cisplatin 75mg/m2 J1J22 or arm Oxaliplatine = oxaliplatine 85mg/m2 every 2 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cisplatin | Arm cisplatin : 75mg/m2, day n\*1 and day n\*22, And radiotherapy 50 Gy, 2Gy/f |
| DRUG | Oxaliplatin | 85 mg/m2 every 2 weeks, 6 times And radiotherapy 50 Gy, 2Gy/f |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2016-08-25
- Last updated
- 2016-08-25
Source: ClinicalTrials.gov record NCT02879227. Inclusion in this directory is not an endorsement.